March 8, 2021 — IBA (Ion Beam Applications S.A., EURONEXT) and NorthStar Medical Radioisotopes, LLC, announced a ...
January 29, 2021 — Fuzionaire Radioisotope Technologies K.K. (“FRIT”) announced that it has entered into a feasibility ...
February 18, 2020 — NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
December 26, 2019 — The Feinstein Institutes for Medical Research has received U.S. Food and Drug Administration (FDA) ...
November 15, 2019 — Theragnostics, which is developing innovative radiopharmaceuticals to improve cancer diagnosis and ...
October 28, 2019 — Phoenix LLC and Shine Medical Technologies LLC, nuclear technology companies focused on near-term ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
October 16, 2019 — GE Healthcare and Theragnostics have entered into a global commercial partnership for a new prostate ...
In a surprising move, the National Institute for Radioelements (IRE) has applied for a new license to export highly ...
August 27, 2019 — The University of Alabama at Birmingham, in conjunction with researchers at the University of ...
August 2, 2019 — The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) ...
July 26, 2019 — NorthStar Medical Radioisotopes LLC has been awarded $15 million in a cooperative agreement with the U.S ...
July 16, 2019 – NorthStar Medical Radioisotopes LLC announced completion of construction on its 20,000-square-foot ...
July 1, 2019 — Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular ...
June 5, 2019 – BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel ...
May 23, 2019 — Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide ...
May 17, 2019 — Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular ...
May 13, 2019 — Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in ...
May 10, 2019 — Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in ...
March 14, 2019 — A team of researchers at the University of Washington announced they developed a new automated system ...
January 30, 2019 - ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the ...